Banque Cantonale Vaudoise Seagen Inc. Transaction History

Banque Cantonale Vaudoise

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$187.64 - $206.25 $14,072 - $15,468	-75 Reduced 10.73%	624 $120,000
Q1 2023 Apr 20, 2023	BUY	$127.59 - $203.08 $49,760 - $79,201	390 Added 126.21%	699 $142,000
Q4 2022 Feb 10, 2023	SELL	$117.37 - $139.17 $4,577 - $5,427	-39 Reduced 11.21%	309 $40,000
Q3 2022 Oct 17, 2022	SELL	$135.27 - $180.11 $372,668 - $496,203	-2,755 Reduced 88.79%	348 $48,000
Q2 2022 Aug 02, 2022	SELL	$108.81 - $179.33 $47,005 - $77,470	-432 Reduced 12.22%	3,103 $549,000
Q2 2021 Aug 11, 2021	SELL	$135.08 - $161.1 $40,524 - $48,330	-300 Reduced 7.82%	3,535 $558,000
Q1 2021 May 11, 2021	BUY	$137.51 - $190.8 $268,694 - $372,823	1,954 Added 103.88%	3,835 $532,000
Q4 2020 Feb 05, 2021	BUY	$164.63 - $211.93 $309,669 - $398,640	1,881 New	1,881 $330,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.